Literature DB >> 28250159

Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion.

Connie M Arthur1, Seema R Patel1, Nicole H Smith1, Ashley Bennett1, Nourine A Kamili1, Amanda Mener1, Christian Gerner-Smidt1, Harold C Sullivan1, J Scott Hale2,3, Andreas Wieland2,3, Benjamin Youngblood2,3, James C Zimring4,5, Jeanne E Hendrickson6, Sean R Stowell7.   

Abstract

Although RBC transfusion can result in the development of anti-RBC alloantibodies that increase the probability of life-threatening hemolytic transfusion reactions, not all patients generate anti-RBC alloantibodies. However, the factors that regulate immune responsiveness to RBC transfusion remain incompletely understood. One variable that may influence alloantibody formation is RBC alloantigen density. RBC alloantigens exist at different densities on the RBC surface and likewise exhibit distinct propensities to induce RBC alloantibody formation. However, although distinct alloantigens reside on the RBC surface at different levels, most alloantigens also represent completely different structures, making it difficult to separate the potential impact of differences in Ag density from other alloantigen features that may also influence RBC alloimmunization. To address this, we generated RBCs that stably express the same Ag at different levels. Although exposure to RBCs with higher Ag levels induces a robust Ab response, RBCs bearing low Ag levels fail to induce RBC alloantibodies. However, exposure to low Ag-density RBCs is not without consequence, because recipients subsequently develop Ag-specific tolerance. Low Ag-density RBC-induced tolerance protects higher Ag-density RBCs from immune-mediated clearance, is Ag specific, and occurs through the induction of B cell unresponsiveness. These results demonstrate that Ag density can potently impact immune outcomes following RBC transfusion and suggest that RBCs with altered Ag levels may provide a unique tool to induce Ag-specific tolerance.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28250159      PMCID: PMC5777137          DOI: 10.4049/jimmunol.1601736

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  70 in total

1.  Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease.

Authors:  Rebecca S McHugh; Ethan M Shevach
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

2.  Forty years of anti-D immunoprophylaxis.

Authors:  Giorgio Reali
Journal:  Blood Transfus       Date:  2007-01       Impact factor: 3.443

3.  Antigen modulation confers protection to red blood cells from antibody through Fcγ receptor ligation.

Authors:  Sean R Stowell; Justine S Liepkalns; Jeanne E Hendrickson; Kathryn R Girard-Pierce; Nicole H Smith; C Maridith Arthur; James C Zimring
Journal:  J Immunol       Date:  2013-10-09       Impact factor: 5.422

4.  Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.

Authors:  Ross M Fasano; Garrett S Booth; Megan Miles; Liping Du; Tatsuki Koyama; Emily Riehm Meier; Naomi L C Luban
Journal:  Br J Haematol       Date:  2014-09-26       Impact factor: 6.998

Review 5.  B cell antigen receptor signaling: roles in cell development and disease.

Authors:  Stephen B Gauld; Joseph M Dal Porto; John C Cambier
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

Review 6.  Formation of mammalian erythrocytes: chromatin condensation and enucleation.

Authors:  Peng Ji; Maki Murata-Hori; Harvey F Lodish
Journal:  Trends Cell Biol       Date:  2011-05-17       Impact factor: 20.808

7.  Red cell alloimmunization in multitransfused HLA-typed patients.

Authors:  S G Brantley; G Ramsey
Journal:  Transfusion       Date:  1988 Sep-Oct       Impact factor: 3.157

8.  Antenatal treatment of neonatal alloimmune thrombocytopenia.

Authors:  J B Bussel; R L Berkowitz; J G McFarland; L Lynch; U Chitkara
Journal:  N Engl J Med       Date:  1988-11-24       Impact factor: 91.245

Review 9.  Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.

Authors:  Alex B Ryder; James C Zimring; Jeanne E Hendrickson
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

10.  An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival.

Authors:  Juan C Scornik; Jonathan S Bromberg; Douglas J Norman; Mayank Bhanderi; Matthew Gitlin; Jeffrey Petersen
Journal:  BMC Nephrol       Date:  2013-10-10       Impact factor: 2.388

View more
  18 in total

Review 1.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

2.  Characterization of glycoprotein IIb/IIIa-specific alloantibodies induced by cross-strain platelet immunization in mice.

Authors:  Daniel W Bougie; Jessica Sutton; Richard H Aster
Journal:  Transfusion       Date:  2021-01-22       Impact factor: 3.157

3.  Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice.

Authors:  Connie M Arthur; Jerry William L Allen; Hans Verkerke; Justin Yoo; Ryan P Jajosky; Kathryn Girard-Pierce; Satheesh Chonat; Patricia Zerra; Cheryl Maier; Jen Rha; Ross Fasano; Cassandra D Josephson; John D Roback; Sean R Stowell
Journal:  Blood Adv       Date:  2021-01-26

4.  Antibody-mediated immune suppression by antigen modulation is antigen-specific.

Authors:  Cheryl L Maier; Amanda Mener; Seema R Patel; Ryan P Jajosky; Ashley L Bennett; Connie M Arthur; Jeanne E Hendrickson; Sean R Stowell
Journal:  Blood Adv       Date:  2018-11-13

5.  Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.

Authors:  Seema R Patel; Ashley Bennett; Kathryn Girard-Pierce; Cheryl L Maier; Satheesh Chonat; Connie M Arthur; Patricia E Zerra; Amanda Mener; Sean R Stowell
Journal:  Blood Adv       Date:  2018-01-23

6.  Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.

Authors:  Fernando Spiller; Corwin M Nycholat; Chika Kikuchi; James C Paulson; Matthew S Macauley
Journal:  J Immunol       Date:  2017-12-29       Impact factor: 5.422

7.  Galectin-9 Is a Novel Regulator of Epithelial Restitution.

Authors:  Brian S Robinson; Bejan Saeedi; Connie M Arthur; Josh Owens; Crystal Naudin; Nourine Ahmed; Liping Luo; Rheinallt Jones; Andrew Neish; Sean R Stowell
Journal:  Am J Pathol       Date:  2020-05-04       Impact factor: 4.307

8.  Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcγ receptors in mice.

Authors:  Amanda Mener; Seema R Patel; Connie M Arthur; Sean R Stowell
Journal:  Transfusion       Date:  2018-11-26       Impact factor: 3.157

9.  Recapitulation of posttransfusion purpura by cross-strain platelet immunization in mice.

Authors:  Daniel W Bougie; Jessica Sutton; Richard H Aster
Journal:  Blood Adv       Date:  2020-01-28

10.  Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A.

Authors:  Patricia E Zerra; Courtney Cox; W Hunter Baldwin; Seema R Patel; Connie M Arthur; Pete Lollar; Shannon L Meeks; Sean R Stowell
Journal:  Blood       Date:  2017-10-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.